Company Overview
Snapshot
Founded in December 2021 by Honny Hillegonda Kipnis Groen and Yossi Kat, ANYCAN TECHNOLOGY operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its AI care platform, STEADY, which has demonstrated an average speed improvement of 25% in six-minute walking tests during proof-of-concept trials.
Business overview
ANYCAN TECHNOLOGY is an Israeli startup developing STEADY, a full-circle AI care platform designed to enhance overall mobility and balance. The platform intuitively corrects and readjusts users' posture in real time, aiming to improve natural head positioning and quality of life. It serves the health tech and life sciences sector, particularly focusing on medical devices and digital healthcare, with applications for conditions like Parkinson's disease and fall prevention. The company collects continuous, objective user data to facilitate app-based interaction with external interfaces and third parties.
Log in to access full profile ›Company Intelligence Q&A
- What is ANYCAN TECHNOLOGY's core product?
- ANYCAN TECHNOLOGY's core product is STEADY, a full-circle AI care platform designed to improve overall mobility and balance by intuitively correcting and readjusting users' posture in real time.
- When was ANYCAN TECHNOLOGY founded and by whom?
- ANYCAN TECHNOLOGY was founded in December 2021 by Honny Hillegonda Kipnis Groen and Yossi Kat.
- What markets does ANYCAN TECHNOLOGY target?
- ANYCAN TECHNOLOGY targets global markets, including Europe, Asia, and the Americas, focusing on the health tech and life sciences sector.
- What stage is ANYCAN TECHNOLOGY currently in?
- ANYCAN TECHNOLOGY is currently in the Pre-Funding stage, with its product, STEADY, in clinical trial development.
- What are the reported results from ANYCAN TECHNOLOGY's proof-of-concept trials?
- ANYCAN TECHNOLOGY's proof-of-concept trials, which included patients with Parkinson's disease, showed an average speed improvement of 25% on the six-minute walking test for all participants. The company also has indications that STEADY may reduce freezing of gait and dyskinesia.